Israeli drug maker Teva announces plan to cut 14,000 jobs as part of global restructuring plan
Israeli drug maker Teva announces plan to cut 14,000 jobs as part of global restructuring plan.
ObamaCare sign-ups gain steam as 2018 deadline nears
More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9.
Novartis generics arm says may sell or end some products
Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on Wednesday.
Hyundai, Kia recall compact cars to fix brake light problem
Hyundai and Kia are recalling more than a half-million compact cars in the U.S. because the brake lights may not go out when the pedal is released.
Ascension, St. Joseph deal would create largest US hospital operator
Two of the nation’s foremost nonprofit hospitals are reportedly in talks to merge – a deal that would form the biggest owner of hospitals in the U.S. – while also potentially exacerbating industry headwinds for the pair.
Viagra is about to get a lot cheaper
Viagra generally costs about $65 per pill, but as competition increases, that price point will decrease substantially.
Baby formula maker calls global recall over salmonella fears
French baby-milk maker Lactalis has ordered a global recall of millions of products over fears of salmonella bacteria contamination.
Hospital operators in merger talks to form U.S. industry leader: WSJ
Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.
Roche lymphoma drug drives high remission rate, longer survival: Study
An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.
Drug companies sue to block California drug price law
Pharmaceutical companies on Friday sued to block a new California law that would require them to give advance notice before big price increases.
Markets Right Now: Jobs, Brexit progress send stocks higher
The latest on developments in financial markets (All times local): 9:35 a.m.
Recalls this week: table lamps, angle grinders, generators
More than 40,000 industrial table lamps are being recalled this week because of a wire that can fray, posing a shock hazard.
Philippines wants money back from Sanofi for dengue vaccine
The Philippine health chief says the government will demand a refund of more than 3 billion pesos ($59 million) from Sanofi Pasteur and look at possible legal action after a study showed its dengue vaccine the country used in an immunization program could expose some people to severe illness.
Subaru, Hyundai top insurance industry's safety awards
Subaru and Hyundai have the most vehicles named top safety picks by the insurance industry.
Veterinarians seek permission to research pot meds for pets
Dr. Byron Maas surveys a supply of marijuana products for dogs that lines a shelf in his veterinary clinic.
As health premiums rise, small businesses seek alternatives
Small businesses are getting notices about their premium and coverage changes for 2018, and some are making adjustments because of that.
Roche drug cocktail doubles chance of halting lung cancer
Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts on Thursday labeled unprecedented.
More than 2,000 drugs now in cancer immunotherapy race
The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.
Obamacare insurance options dwindle for neediest U.S. patients
The challenge of finding adequate healthcare on the Obamacare market is expected to intensify as the Trump administration strips away aspects of the law, healthcare experts say.
UnitedHealth ventures deeper into care with nearly $5B deal
The nation's biggest health insurer is spending nearly $5 billion to buy hundreds of clinics, just three days after rival Aetna announced a tie up with CVS Health.













